Multi-Division PCD Pharma Franchise · WHO-GMP Certified · Telephone: +91 97658 93730 · Submit Application
4th Generation Cephalosporin · Critical Care

FRILOPIME-1000

Cefepime 1000mg Injection

Fourth-generation cephalosporin with broad gram-positive and gram-negative coverage, including Pseudomonas aeruginosa.

Enquire / Get Quote   WhatsApp Enquiry

FRILOPIME 1000 by Biofril Healthcare — WHO-GMP manufactured
At a Glance

Product Specifications

Brand NameFRILOPIME-1000
Generic / CompositionCefepime (as hydrochloride monohydrate) IP equivalent to Cefepime 1000mg
Therapeutic Category4th Generation Cephalosporin
Dosage FormLyophilized powder for injection
Strength1000mg
Route of AdministrationIntravenous / Intramuscular
Pack Size1 Vial with WFI
StorageStore below 25°C. Protect from light.
ManufacturerBiofril Healthcare Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP
Prescription StatusRx — To be sold by retail on the prescription of a Registered Medical Practitioner
Clinical Use

Indications & Clinical Applications

FRILOPIME-1000 is indicated for moderate to severe infections caused by susceptible organisms, particularly when broad-spectrum coverage including Pseudomonas is required.

  • Lower respiratory tract infections (pneumonia, bronchitis)
  • Complicated and uncomplicated urinary tract infections
  • Skin and soft tissue infections
  • Complicated intra-abdominal infections (with metronidazole)
  • Empirical therapy for febrile neutropenia
  • Septicaemia
Why Biofril FRILOPIME-1000

Product Features

  • Effective against Pseudomonas aeruginosa
  • Stable against many beta-lactamases
  • Suitable for ICU and tertiary care use
  • WHO-GMP manufactured
  • Hospital tender ready documentation
Safety Information

Warnings & Precautions

Use with caution in patients with penicillin hypersensitivity. Adjust dose in renal impairment. May cause neurotoxicity (myoclonus, seizures) in renal impairment if dose not adjusted. Monitor for C. difficile diarrhoea.

This information is intended for healthcare professionals only. Always consult the complete product insert and a registered medical practitioner before prescribing or using. Biofril Healthcare is committed to pharmacovigilance — please report any adverse events to biofrilhealthcare@gmail.com.

Enquire About FRILOPIME-1000

PCD franchise · Hospital tenders · Bulk supply · Distribution opportunities

Get Quote & Net Rate   Call +91 97658 93730   WhatsApp

← Back to Critical Care Range  |  Critical Care PCD Franchise →